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Results: Our method proved to be effective in evaluating 
Rectum DVH in Phamtom,76Gy (non, 4.433%) (3mm,0%) 
(5mm,0.171%)(7mm0.502%)(9mm,0.163%),75Gy(non, 5.344%) 
(3mm,0.186%)(5mm,2.476%)(7mm,3.171%)(9mm,3.191) 
 
 
 
Conclusions: Comparion of rectum dose data suggested that 
with dummy structure was significantly low.  
76Gy(F4,45)=212.64 P<0.001, 75Gy(F 4,45)=5.637 P<0.001) 
It is concluded that our method for reducing high dose in 
rectum is very efficient. 
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Purpose/Objective: Mycosis Fungoide is the most frequently 
observed Cutaneous T-Cell Lymphoma (CTCL) with an 
indolent evolution characterized by cutaneous lesions in 
forms of patches, plaques or skin tumors. TSEBT has been 
used in the treatment of various skin diseases either for 
curative or palliative purposes. With this method, the entire 
surface of the body is treated uniformly to a limited depth. 
TSEBT can be performed by three methods: standing patient 
technique, rotary method and translational approach. 
The aim of this study is to evaluate the homogeneity of dose 
distribution in the broad electron fields. 
Materials and Methods: At onset of the study dosimetry was 
performed on a RANDO phantom. In this process, the RANDO 
phantom was set in the standing position at the fixed 
distance from the isocentre (SSD=400 cm). Dose 
measurements were obtained by placing TLDs in the hole 
grids near the skin surface which are contrived at all sections 
of the phantom. Then TSEBT was performed on an 
erythodermic mycosis fungoides candidate (old female 
patient, age: 54 years old).  Stanford technique was 
implemented for treatment of this patient.The biggest 
electron applicator (25×25cm2) was applied at distance of 400 
cm from the isocentre. Because of inadequate field coverage, 
two electron therapeutic fields were matched at each 
direction of patient positioning. Figure 1 shows the schematic 
patient positioning. 
 
 
Figure 1. The position of patient in each treatment field. 
 This method was done both for upper and lower limbs. 
Gantry angle was set to be 90°, electron beam energy was 6 
MeV and also 100cGy per fraction (33 cGy per each field) in 
36 fractions were uniformly irradiated (±10%) along the 
patient body. 
Results: The results of dosimetry on phantom and patient 
skin showed that a uniform absorbed dose was obtained along 
the patient body with the maximum standard deviation of 
±10%. Figure 2 shows the position of the tested points and 
the corresponding results are tabulated in table 1.  
 
 
Figure 2. The position of the tested points. 
  
Table 1. The corresponding results of absorbed dose at the 
tested points.  
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The results of dosimetry (table 1) show a uniform dose 
distribution on skin surface of the patient.The maximum and 
minimum absorbed doses were 35.80 and 32.35 cGy which 
are equal to 104.48% and 98.03% of the prescribed dose, 
respectively.  
Variability of dose distribution in different points of patient 
skin arises from two elements:statistical errors, experimental 
uncertainties and irregular surface contouring. 
Conclusions: By providing homogeneous dose coverage on 
patient skin, TSEBT can be considered as one of the most 
excellent and effective palliative and curative therapeutic 
modalities for Mycosis Fungoide. 
Uniform dose distribution needs an appropriate patient 
positioning and the results of treatment depend on the total 
dose  
and number of fractions which are determined by staging of 
cancer.  
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Purpose/Objective: To evaluate three different techniques: 
3D-CRT, IMRT and VMAT and their ability to spare organs at 
risk (OAR) in rectal carcinoma patients. In addition, to 
establish a set of inverse planning parameters (class solution) 
for this tumor group. 
Materials and Methods: 40 patients with locally advanced 
rectal carcinoma were included in the study, of which 20 
patients presented with hip prostheses (unilateral or 
bilateral), and 20 patients without (standard group). PTV 
expansion from CTV was done with anisotropic margins: 7 mm 
in dorsal and lateral direction, 15 mm in anterior direction 
and 10 mm in cranio-caudal direction. PTV volumes ranged 
from 445 cc to 1622 cc. 
3D-CRT plans consisted of one posterior field and two 
opposing, lateral fields. IMRT plans were created with 7 
equidistant fields (260, 770, 1280, 1800, 2310, 2830 and 3340), 
and VMAT plans were produced with 2 arcs (VMAT-2ARC) and 
4 arcs (VMAT-4ARC). For patients with hip prostheses the 
beam configuration of the 3D-CRT and IMRT plans was altered 
avoiding the prostheses, and in the case of VMAT avoidance 
sectors were introduced. 
All plans were normalized to cover 98% of the PTV with 95% 
of the prescribed dose (50.4 Gy). With the D2% (Dnear-max), Dmean 
and V90% parameters of the Anal Channel (AC), Bladder (BL), 
Intergluteal Cleft (IC), Small Bowel (SB) and Perineum (PE), 
the dose to the OAR minus PTV was evaluated. 
Results: For all patients a significant reduction of high (V90%) 
and mean dose was seen in all OAR (Dmean: AC: -51%, BL:-22%, 
IC: - 55%, SB: -30%, PE: -52%; p < 0.001) for the IMRT/VMAT 
plans compared to 3D-CRT (Figure 1 and Table 1). In these 
plans, D2% in all OAR was also significantly lower (AC: -22%, 
BL:-11%, IC: -53%, SB: -15%, PE: -45%; p<0.001). Regarding 
dose to the PTV, IMRT plans resulted in a higher D2% in all 
patients (ca. 1 Gy, p< 0.001), whereas the D2% for the PTV in 
VMAT plans was not significantly different to that of 3D-CRT 
plans. 
 
For the group of patients with hip prostheses ,VMAT-4ARC 
plans produced the best and significant sparing of all OAR (p 
< 0.001). In the standard group differences between IMRT and 
VMAT were small and only significant for the small bowel 
(lower doses with VMAT, p < 0.001).  
Because VMAT plans produced overall the most homogeneous 
plans and best sparing of OAR, three class solutions with this 
technique (standard, unilateral or bilateral prostheses) were 
derived with sets of constraints and objectives covering the 
majority of patients. 
 
Conclusions: Significantly lower doses to OAR are achieved 
with the use of IMRT/VMAT treatment techniques compared 
to 3D-CRT, which may lead to less toxicity after preoperative 
chemoradiation for locally advanced rectal carcinoma. In 
